Clinical Trial Update: Study of NM8074 in Patients with Dermatomyositis (DM) [Phase 2]

View source ↗

Summary

This is an update on a Phase 2 clinical trial evaluating NM8074 for dermatomyositis, currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dermatomyositis

Drugs mentioned

• NM8074

Snippet

Sponsor: NovelMed Therapeutics | Conditions: Dermatomyositis | Phase 2 | Status: NOT_YET_RECRUITING